Trends in Uterine Cancer Cases after the Coronavirus Disease 2019 (COVID-19) Pandemic

Nathan Tran; Joshua E. Chan; Chelsea Stewart; Caitlin R. Johnson; Kathleen Darcy; Chunqiao Tian; Daniel S. Kapp; Cheng I. Liao; John K. Chan

doi:10.1097/AOG.0000000000005731

Trends in Uterine Cancer Cases after the Coronavirus Disease 2019 (COVID-19) Pandemic

Nathan Tran, Joshua E. Chan, Chelsea Stewart, Caitlin R. Johnson^*, Kathleen Darcy, Chunqiao Tian, Daniel S. Kapp, Cheng I. Liao, John K. Chan

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

We assessed the temporal trends in diagnosis of uterine cancer before and during the coronavirus disease 2019 (COVID-19) pandemic using data from the United States Cancer Statistics database spanning from 2001 to 2020. A comparison between projected and observed new cases in 2020 revealed a 4,232-case discrepancy, indicating 9.3% fewer diagnosed cases than predicted based on trends. Hispanic and Asian and Pacific Islander patients exhibited the highest discrepancy at 14.6% and 12.0% fewer cases, respectively, compared with 8.6% and 6.9% for White and Black patients. Our results highlight the importance of targeting health resources toward vulnerable populations in an effort to address accumulated cases of uterine cases after the pandemic.

Original language	English
Pages (from-to)	829-831
Number of pages	3
Journal	Obstetrics and gynecology
Volume	144
Issue number	6
DOIs	https://doi.org/10.1097/AOG.0000000000005731
State	Published - 1 Dec 2024
Externally published	Yes

Access to Document

10.1097/AOG.0000000000005731

Cite this

@article{3cfb8008d826463091aa1994a813e155,

title = "Trends in Uterine Cancer Cases after the Coronavirus Disease 2019 (COVID-19) Pandemic",

abstract = "We assessed the temporal trends in diagnosis of uterine cancer before and during the coronavirus disease 2019 (COVID-19) pandemic using data from the United States Cancer Statistics database spanning from 2001 to 2020. A comparison between projected and observed new cases in 2020 revealed a 4,232-case discrepancy, indicating 9.3% fewer diagnosed cases than predicted based on trends. Hispanic and Asian and Pacific Islander patients exhibited the highest discrepancy at 14.6% and 12.0% fewer cases, respectively, compared with 8.6% and 6.9% for White and Black patients. Our results highlight the importance of targeting health resources toward vulnerable populations in an effort to address accumulated cases of uterine cases after the pandemic.",

author = "Nathan Tran and Chan, {Joshua E.} and Chelsea Stewart and Johnson, {Caitlin R.} and Kathleen Darcy and Chunqiao Tian and Kapp, {Daniel S.} and Liao, {Cheng I.} and Chan, {John K.}",

year = "2024",

month = dec,

day = "1",

doi = "10.1097/AOG.0000000000005731",

language = "English",

volume = "144",

pages = "829--831",

journal = "Obstetrics and gynecology",

issn = "0029-7844",

number = "6",

}

TY - JOUR

T1 - Trends in Uterine Cancer Cases after the Coronavirus Disease 2019 (COVID-19) Pandemic

AU - Tran, Nathan

AU - Chan, Joshua E.

AU - Stewart, Chelsea

AU - Johnson, Caitlin R.

AU - Darcy, Kathleen

AU - Tian, Chunqiao

AU - Kapp, Daniel S.

AU - Liao, Cheng I.

AU - Chan, John K.

PY - 2024/12/1

Y1 - 2024/12/1

N2 - We assessed the temporal trends in diagnosis of uterine cancer before and during the coronavirus disease 2019 (COVID-19) pandemic using data from the United States Cancer Statistics database spanning from 2001 to 2020. A comparison between projected and observed new cases in 2020 revealed a 4,232-case discrepancy, indicating 9.3% fewer diagnosed cases than predicted based on trends. Hispanic and Asian and Pacific Islander patients exhibited the highest discrepancy at 14.6% and 12.0% fewer cases, respectively, compared with 8.6% and 6.9% for White and Black patients. Our results highlight the importance of targeting health resources toward vulnerable populations in an effort to address accumulated cases of uterine cases after the pandemic.

AB - We assessed the temporal trends in diagnosis of uterine cancer before and during the coronavirus disease 2019 (COVID-19) pandemic using data from the United States Cancer Statistics database spanning from 2001 to 2020. A comparison between projected and observed new cases in 2020 revealed a 4,232-case discrepancy, indicating 9.3% fewer diagnosed cases than predicted based on trends. Hispanic and Asian and Pacific Islander patients exhibited the highest discrepancy at 14.6% and 12.0% fewer cases, respectively, compared with 8.6% and 6.9% for White and Black patients. Our results highlight the importance of targeting health resources toward vulnerable populations in an effort to address accumulated cases of uterine cases after the pandemic.

UR - http://www.scopus.com/inward/record.url?scp=85210943645&partnerID=8YFLogxK

U2 - 10.1097/AOG.0000000000005731

DO - 10.1097/AOG.0000000000005731

M3 - Article

C2 - 39601704

AN - SCOPUS:85210943645

SN - 0029-7844

VL - 144

SP - 829

EP - 831

JO - Obstetrics and gynecology

JF - Obstetrics and gynecology

IS - 6

ER -